Citation: B. Rist et al., FROM MICROMOLAR TO NANOMOLAR AFFINITY - A SYSTEMATIC-APPROACH TO IDENTIFY THE BINDING-SITE OF CGRP AT THE HUMAN CALCITONIN-GENE-RELATED PEPTIDE-1 RECEPTOR, Journal of medicinal chemistry, 41(1), 1998, pp. 117-123
Authors:
DOODS HN
WIELAND HA
ENGEL W
EBERLEIN W
WILLIM KD
ENTZEROTH M
WIENEN W
RUDOLF K
Citation: Hn. Doods et al., BIBP-3226, THE FIRST SELECTIVE NEUROPEPTIDE Y1 RECEPTOR ANTAGONIST - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, Regulatory peptides, 65(1), 1996, pp. 71-77
Authors:
DOODS HN
WIENEN W
ENTZEROTH M
RUDOLF K
EBERLEIN W
ENGEL W
WIELAND HA
Citation: Hn. Doods et al., PHARMACOLOGICAL CHARACTERIZATION OF THE SELECTIVE NONPEPTIDE NEUROPEPTIDE-Y Y1 RECEPTOR ANTAGONIST BIBP-3226, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 136-142
Authors:
WIELAND HA
WILLIM KD
ENTZEROTH M
WIENEN W
RUDOLF K
EBERLEIN W
ENGEL W
DOODS HN
Citation: Ha. Wieland et al., SUBTYPE SELECTIVITY AND ANTAGONISTIC PROFILE OF THE NONPEPTIDE Y1 RECEPTOR ANTAGONIST BIBP-3226, The Journal of pharmacology and experimental therapeutics, 275(1), 1995, pp. 143-149
Authors:
ENTZEROTH M
BRAUNGER H
EBERLEIN W
ENGEL W
RUDOLF K
WIENEN W
WIELAND HA
WILLIM KD
DOODS HN
Citation: M. Entzeroth et al., LABELING OF NEUROPEPTIDE-Y RECEPTORS IN SK-N-MC CELLS USING THE NOVEL, NONPEPTIDE Y-1 RECEPTOR-SELECTIVE ANTAGONIST [H-3] BIBP3226, European journal of pharmacology, 278(3), 1995, pp. 239-242
Authors:
VANMEEL JCA
ENTZEROTH M
REDEMANN N
HAIGH RM
Citation: Jca. Vanmeel et al., EFFECTS OF PIMOBENDAN AND ITS METABOLITE ON MYOFIBRILLAR CALCIUM RESPONSIVENESS AND ATPASE ACTIVITY IN THE PRESENCE OF INORGANIC-PHOSPHATE, Arzneimittel-Forschung, 45-1(2), 1995, pp. 136-141
Citation: W. Wienen et M. Entzeroth, EFFECTS ON BINDING CHARACTERISTICS AND VENAL FUNCTION OF THE NOVEL, NONPEPTIDE ANGIOTENSIN-II ANTAGONIST BIBR-277 IN THE RAT, Journal of hypertension, 12(2), 1994, pp. 119-128
Authors:
RUDOLF K
EBERLEIN W
ENGEL W
WIELAND HA
WILLIM KD
ENTZEROTH M
WIENEN W
BECKSICKINGER AG
DOODS HN
Citation: K. Rudolf et al., THE FIRST HIGHLY POTENT AND SELECTIVE NONPEPTIDE NEUROPEPTIDE-Y Y-1-RECEPTOR ANTAGONIST - BIBP3226, European journal of pharmacology, 271(2-3), 1994, pp. 11-13
Authors:
DOODS HN
ENTZEROTH M
ZIEGLER H
MAYER N
HOLZER P
Citation: Hn. Doods et al., PHARMACOLOGICAL PROFILE OF SELECTIVE MUSCARINIC RECEPTOR ANTAGONISTS ON GUINEA-PIG ILEAL SMOOTH-MUSCLE, European journal of pharmacology, 253(3), 1994, pp. 275-281
Authors:
SCHAMBYE HT
VONWIJK B
HJORTH SA
WIENEN W
ENTZEROTH M
BERGSMA DJ
SCHWARTZ TW
Citation: Ht. Schambye et al., MUTATIONS IN TRANSMEMBRANE SEGMENT-VII OF THE AT(1) RECEPTOR DIFFERENTIATE BETWEEN CLOSELY-RELATED INSURMOUNTABLE AND COMPETITIVE ANGIOTENSIN ANTAGONISTS, British Journal of Pharmacology, 113(2), 1994, pp. 331-333
Authors:
RIES UJ
MIHM G
NARR B
HASSELBACH KM
WITTNEBEN H
ENTZEROTH M
VANMEEL JCA
WIENEN W
HAUEL NH
Citation: Uj. Ries et al., 6-SUBSTITUTED BENZIMIDAZOLES AS NEW NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - SYNTHESIS, BIOLOGICAL-ACTIVITY, AND STRUCTURE-ACTIVITY-RELATIONSHIPS, Journal of medicinal chemistry, 36(25), 1993, pp. 4040-4051
Authors:
DOODS H
ENTZEROTH M
ZIEGLER H
SCHIAVI G
ENGEL W
MIHM G
RUDOLF K
EBERLEIN W
Citation: H. Doods et al., CHARACTERIZATION OF BIBN-99 - A LIPOPHILIC AND SELECTIVE MUSCARINIC M(2)-RECEPTOR ANTAGONIST, European journal of pharmacology, 242(1), 1993, pp. 23-30
Authors:
WIENEN W
HAUEL N
VANMEEL JCA
NARR B
RIES U
ENTZEROTH M
Citation: W. Wienen et al., PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, BIBR-277, British Journal of Pharmacology, 110(1), 1993, pp. 245-252